Non-Communicable Disease Prevention
Best Buys, Wasted Buys and Contestable Buys
Non-communicable diseases (NCDs) are the leading cause of death worldwide, contributing to over 73% of all deaths annually. Each day NCDs cause more than 100,000 deaths, 80% of which occur in low- and middle-income countries. NCDs, however, are largely preventable, and a great deal of technical knowledge exists about how to prevent and manage them. Why, then, have we, as a global community, not been more successful at reducing this NCD burden? Does a universal problem not have a universal solu...
Note de l’éditeur
Online Appendixes: https://hdl.handle.net/20.500.12434/09617d51
Éditeur : Open Book Publishers
Lieu d’édition : Cambridge
Publication sur OpenEdition Books : 8 juin 2021
ISBN numérique : 979-10-365-6082-8
Collection : OBP collection
Année d’édition : 2019
ISBN (Édition imprimée) : 978-1-78374-863-1
Nombre de pages : xxx-220
Vicharn Panich, Churnrurtai Kanchanachitra et Dean T. Jamison
ForewordsWanrudee Isaranuwatchai, Rachel A. Archer et Anthony J. Culyer
1. IntroductionSumithra Krishnamurthy Reddiar et Jesse Boardman Bump
2. Non-Communicable Diseases, NCD Program Managers and the Politics of ProgressYot Teerawattananon, Alia Luz, Manushi Sharma et al.
3. Framework for Implementing Best Buys and Avoiding Wasted BuysTazeem Bhatia, Arisa Shichijo et Ryota Nakamura
4. Best BuysYot Teerawattananon, Manushi Sharma, Alia Luz et al.
5. Wasted BuysDavid D. Kim, Rachel L. Bacon et Peter J. Neumann
6. Assessing the Transferability of Economic EvaluationsA Decision Framework
Thunyarat Anothaisintawee
7. Finding the Best EvidenceMelitta Jakab et Peter C. Smith
8. Cross-Sectoral Policies to Address Non-Communicable DiseasesKalipso Chalkidou et Anthony J. Culyer
9. Deliberative Processes in Decisions about Best Buys, Wasted Buys and Contestable BuysUncertainty and Credibility
Wanrudee Isaranuwatchai, Rachel A. Archer et Anthony J. Culyer
10. Summing UpNon-communicable diseases (NCDs) are the leading cause of death worldwide, contributing to over 73% of all deaths annually. Each day NCDs cause more than 100,000 deaths, 80% of which occur in low- and middle-income countries. NCDs, however, are largely preventable, and a great deal of technical knowledge exists about how to prevent and manage them. Why, then, have we, as a global community, not been more successful at reducing this NCD burden? Does a universal problem not have a universal solution?
Created by an international consortium of experts, this informative and accessible book provides practical guidelines, key learning points, and dynamic, real-world case studies to aid NCD program managers, policy officers and decision-makers in low- and middle-income countries, so that they can assess interventions for the prevention and control of NCDs.
The book comprises ten chapters, which collectively explore the reasons behind, and strategies for, preventing and managing the NCD burden. It spans key themes such as political economy, the transferability of economic evidence, the role of cross-sectoral policies, the importance of deliberative processes, and health technology assessment.
NCD Prevention is written for the benefit of the global health community, and is primarily targeted at those individuals who are involved in NCD programs. This book will also be of interest to NCD champions, policy advocates, and educators spearheading the movement for increased visiblity of NCDs.
Wanrudee Isaranuwatchai (dir.)
Wanrudee Isaranuwatchai, Ph.D., is a Senior Researcher at the Health Intervention and Technology Assessment Program (a part of the Ministry of Public Health) in Bangkok, Thailand, a Director at the Centre for Excellence in Economic Analysis Research of St. Michael’s Hospital and a Senior Health Economist at the Canadian Centre for Applied Research in Cancer Control in Canada. She is also an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto. Her research focuses on how to apply economic evaluation in the real world setting as well as how to advance methods in economic evaluation. She has experience conducting economic evaluations using person-level data and decision modelling. She has collaborated with researchers and decision-makers in various areas to help communicate the value of health initiatives using economic evidence. Dr. Isaranuwatchai is dedicated to promoting the use of evidence in healthcare decision making.
Rachel A. Archer (dir.)
Rachel A. Archer, M.P.H., is a Project Associate at the Health Intervention and Technology Assessment Program (HITAP). Her work focuses on health system strengthening and supporting evidence-informed health policy making in low- and middle-income countries (LMICs). She is the focal point at HITAP for the Total Systems Effectiveness (TSE) project, an approach to strengthen vaccine decision-making in LMICs, and she currently leads the PMAC Commissioned Work project. Rachel has also supported capacity-building activities for Indonesia, Kenya and The Philippines. Rachel holds a Master’s degree in Public Health from the University of Sheffield and a Bachelor of Arts in International Development from the University of Leeds. Whilst studying, she interned with various non-profit organizations across East and West Africa. For her Master’s thesis, Rachel collaborated with a non-profit to investigate the trend towards teenage pregnancy in Luwero District, Uganda, through an intersectional framework. She was awarded the Carpenter Prize for Best Dissertation.
Yot Teerawattananon (dir.)
Yot Teerawattananon, MD., Ph.D., is the founding leader of the Health Intervention and Technology Assessment Program (HITAP), which is a semi-autonomous research institute of Thailand’s Ministry of Public Health. The works of HITAP have been used to inform policy decisions regarding the adoption of medicines, medical devices, health promotion and disease prevention programmes under the Universal Health Coverage Scheme and the national pharmaceutical reimbursement list, the National List of Essential Medicines. Recently, he joins the National University of Singapore as a visiting professor at Saw Swee Hock School of Public Health as well as is the Executive Board of the international Decision Support Initiative (iDSI). He has published more than 140 peer-reviewed journal articles and provided technical support on HTA capacity building in Asia and Africa. He is also one of the founders of HTAsiaLink, a regional network comprising governmental health technology assessment agencies in the Asia and Pacific region.
Anthony J. Culyer (dir.)
Anthony J. Culyer, Ph.D., is Emeritus Professor of Economics at the University of York (England), Senior Fellow at the Institute of Health Policy, Management and Evaluation at the University of Toronto (Canada) and Visiting Professor at Imperial College London. He is Chair of the Board of the international Decision Support Initiative (iDSI). He was the founding Organizer of the Health Economists’ Study Group. For thirty-three years he was the founding Co-Editor, with Joe Newhouse at Harvard, of Journal of Health Economics. He was founding Vice Chair of the National Institute for Health and Care Excellence (NICE) until 2003. He is Editor-in-Chief of the online Encyclopaedia of Health Economics. For many years he was chair of the Department of Economics & Related Studies at York and, for six of them, was also deputy vice-chancellor. He has published widely, mostly in health economics.

Le texte seul est utilisable sous licence Creative Commons - Attribution 4.0 International - CC BY 4.0. Les autres éléments (illustrations, fichiers annexes importés) sont « Tous droits réservés », sauf mention contraire.